American Orthopedic Surgeon and Stem Cell Researcher Presents at XXXIV. Červeňansky days, the national meeting of Slovak orthopaedic and traumatologic society (SOTS)

Brian Mehling, M.D., a board-certified orthopedic surgeon and CMO of Blue Horizon International, presented his study on clinical applications of mesenchymal stem cells

News provided by

Blue Horizon International

Mar 23, 2016, 04:26 ET

NEW YORK, March 23, 2016 /PRNewswire/ -- Internationally recognized stem cell researcher and chief medical officer of Blue Horizon International (BHI) and BHI Therapeutic Sciences, Brian Mehling, M.D. presented at the XXXIV. Červeňansky days, the national meeting of Slovak orthopaedic and traumatologic society. (SOTS).

The annual SOTS meeting was held March 10 - 11, 2016 at the Holiday Inn Hotel in Bratislava, Slovakia.

Attending annual SOTS meeting are, from left: Dr Robert Vetrak, medical director, Lenka Gondova, PR, Ing Peter Kalencik, MSc, CEO, and sales representatives all of Malacky Hospital; Brian Mehling M.D., CMO and Founder of Blue Horizon International

Researchers, medical practitioners, and company representatives from around the world came together at the Hotel Congress Center to present and discuss the latest developments and findings in the fields of orthopaedic and traumatologic society.

The event has evolved into an outstanding platform for networking and for showcasing joint scientific work in the field of orthopedics.

"Stem cell therapies are, without a doubt, the future of medicine and we believe their role in orthopaedic and traumatologic society will become the preferred substitutes for many surgical, pharmacological, and rehabilitative medical services," Dr. Mehling stated. "It is important that doctors and medical professionals are educated on what direction the world will take in regard to stem cell research and therapies. The possibilities are endless. It is crucial for physicians to be aware of the therapies available for orthopedic patients."

BHI Therapeutic Sciences, LLC is currently offering cord blood, bone marrow and adipose stem cell derived treatments at Malacky Hospital in Slovakia and is fully licensed by the Ministry of Health of the Slovak Republic.

Blue Horizon International is a healthcare consulting company with a unique mission that combines treatment, research and philanthropic efforts. Across the globe quality care and services for medical treatments are provided along with resources needed to assist children and adults who are medically underserved. For more information, please visit Blue Horizon International at www.bluehorizoninternational.com.

Červeňansky Days - National Congress of SOTS

As a tribute to the academic Ján Červeňanský, the Slovak orthopaedic and traumatologic society annually organizes its National Congress - Červeňanského days, every year.
He was an honorary member of the Czechoslovak, Slovak, Polish, Bulgarian, Yugoslav and East German orthopedic societies, a memeber of SICOT, the Royal Society of Medicine, Academia Leopoldina in Halle and won many other recognitions. Professor Červeňanský, the founder of modern Slovak orthopedics, died in 1977 in Bratislava. For more information, please visit www.cervenanskehodni.sk/en.

Photo - http://photos.prnewswire.com/prnh/20160323/347538

SOURCE Blue Horizon International